Answers are grounded in this paper and cite their sources.
Donor livers with macrovesicular steatosis are disproportionately not transplanted relative to their risk for graft failure. To avoid undue risk aversion, SRTR now accounts for macrovesicular steatosis in the SRTR risk-adjustment models to help facilitate use of these higher-risk organs. Increased recognition of this variable may also encourage further efforts to standardize the reporting of liver biopsy results.
No takes yet. Share an insight, caveat, or question.
Kwong et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: